34 min
Dnext: SCIMAR Dnext
-
- Documentary
John West of Scimar.
SciMar Ltd. was founded in 2009 to advance the pioneering medical research of Dr. Wayne Lautt and his team as they work to unveil hepatalin* as the foundation of a new paradigm in the prevention and treatment of type 2 diabetes.
Based in Manitoba, Canada, SciMar is driven by a passion to change the course of human health as type 2 diabetes exacts a frightful toll on communities around the world. Rates of type 2 diabetes and the conditions that lead to it—especially obesity—are skyrocketing everywhere. The current paradigms for preventing and treating type 2 diabetes are not working.
Through rigorous science, deep passion, and significant investment, SciMar has made important progress in the lab; has moved through the early stages of regulatory approval in Canada and the United States; and has protected key elements of its intellectual property and product pipeline with patents in 10 countries.
Clinical trials are moving forward; a change in global health and well-being is on the horizon. Investors are invited to join the journey.
John West of Scimar.
SciMar Ltd. was founded in 2009 to advance the pioneering medical research of Dr. Wayne Lautt and his team as they work to unveil hepatalin* as the foundation of a new paradigm in the prevention and treatment of type 2 diabetes.
Based in Manitoba, Canada, SciMar is driven by a passion to change the course of human health as type 2 diabetes exacts a frightful toll on communities around the world. Rates of type 2 diabetes and the conditions that lead to it—especially obesity—are skyrocketing everywhere. The current paradigms for preventing and treating type 2 diabetes are not working.
Through rigorous science, deep passion, and significant investment, SciMar has made important progress in the lab; has moved through the early stages of regulatory approval in Canada and the United States; and has protected key elements of its intellectual property and product pipeline with patents in 10 countries.
Clinical trials are moving forward; a change in global health and well-being is on the horizon. Investors are invited to join the journey.
34 min